American Century Companies Inc. Has $90.65 Million Stake in Mettler-Toledo International, Inc. $MTD

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

American Century Companies Inc. decreased its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 6.0% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 76,761 shares of the medical instruments supplier's stock after selling 4,935 shares during the quarter. American Century Companies Inc. owned about 0.37% of Mettler-Toledo International worth $90,648,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in MTD. Ethic Inc. raised its stake in Mettler-Toledo International by 1.6% in the 1st quarter. Ethic Inc. now owns 2,440 shares of the medical instruments supplier's stock valued at $2,822,000 after acquiring an additional 39 shares during the period. Martin Currie Ltd. boosted its position in Mettler-Toledo International by 3.9% during the first quarter. Martin Currie Ltd. now owns 57,992 shares of the medical instruments supplier's stock worth $68,483,000 after purchasing an additional 2,180 shares during the period. Horizon Investments LLC increased its holdings in shares of Mettler-Toledo International by 4.2% in the first quarter. Horizon Investments LLC now owns 299 shares of the medical instruments supplier's stock valued at $353,000 after purchasing an additional 12 shares during the last quarter. OneAscent Investment Solutions LLC bought a new position in shares of Mettler-Toledo International in the first quarter valued at about $468,000. Finally, Tokio Marine Asset Management Co. Ltd. lifted its stake in shares of Mettler-Toledo International by 46.7% during the 1st quarter. Tokio Marine Asset Management Co. Ltd. now owns 7,829 shares of the medical instruments supplier's stock worth $9,245,000 after buying an additional 2,493 shares during the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Down 3.0%

Shares of NYSE:MTD traded down $39.4530 during midday trading on Thursday, hitting $1,277.4270. The stock had a trading volume of 138,895 shares, compared to its average volume of 174,321. The company's 50-day moving average price is $1,222.56 and its 200-day moving average price is $1,189.69. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,521.01. The company has a market capitalization of $26.31 billion, a P/E ratio of 32.35, a price-to-earnings-growth ratio of 3.97 and a beta of 1.34.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. During the same period last year, the firm posted $9.65 earnings per share. The firm's quarterly revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Research analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on MTD. Citigroup lifted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their price objective for the stock from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Robert W. Baird upped their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Wall Street Zen lowered Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Finally, Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and dropped their price target for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Mettler-Toledo International has an average rating of "Moderate Buy" and a consensus target price of $1,311.11.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the business's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider owned 94 shares of the company's stock, valued at approximately $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the business's stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director directly owned 283 shares of the company's stock, valued at approximately $368,154.70. The trade was a 78.96% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 2,889 shares of company stock valued at $3,603,054. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.